Clinical Trial Update: Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells [Phase 2]

View source ↗

Summary

Phase 2 trial investigating atorvastatin for inflammation, coagulopathy, angiogenesis, and T-cell biomarkers in HIV-1 infection has completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: HIV-1 Infection | Phase 2 | Status: COMPLETED | Results posted: 2015-08-04